UCART

Clinical trials for UCART explained in plain language.

Never miss a new study

Get alerted when new UCART trials appear

Sign up with your email to follow new studies for UCART, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Engineered immune cells take on tough blood disorder

Disease control Recruiting now

This study tests a new treatment called CAR-T cell therapy for people with a severe type of autoimmune anemia that hasn't improved with standard treatments. The therapy uses specially modified immune cells from a donor to target and destroy the faulty immune cells causing the dis…

Matched conditions: UCART

Phase: EARLY_PHASE1 • Sponsor: The Second Hospital of Anhui Medical University • Aim: Disease control

Last updated May 22, 2026 13:52 UTC

UCART

Get alerted when new UCART trials appear

Engineered immune cells take on tough blood disorder